Convergence Investment Partners’s Halozyme HALO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.43M	Buy	37,599 +6,748	+22%	+$476K	0.4%	78
2025 Q4	$2.08M	Buy	30,851 +10,766	+54%	+$724K	0.41%	74
2025 Q3	$1.47M	Sell	20,085 -7,390	-27%	-$491K	0.33%	102
2025 Q2	$1.43M	Sell	27,475 -1,064	-4%	-$60.5K	0.36%	92
2025 Q1	$1.82M	Sell	28,539 -6,174	-18%	-$359K	0.5%	57
2024 Q4	$1.66M	Buy	34,713 +7,151	+26%	+$367K	0.37%	96
2024 Q3	$1.58M	Buy	27,562 +1,316	+5%	+$75.4K	0.43%	73
2024 Q2	$1.37M	Buy	+26,246	New	+$1.15M	0.4%	71
2024 Q1	–	Sell	-7,008	Closed	-$259K	–	255
2023 Q4	$259K	Buy	+7,008	New	+$264K	0.14%	154
2016 Q1	–	Sell	-172,134	Closed	-$2.98M	–	364
2015 Q4	$2.98M	Sell	172,134 -79,614	-32%	-$1.27M	0.33%	109
2015 Q3	$3.38M	Buy	+251,748	New	+$5.05M	0.39%	91